Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 3/20 | 0.55 |
| ▸ | PPARA | Q07869 | 3/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.55 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.53 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4746588 | 0.90 | PPARG (0.61) | PPARGPPARACYP2C9KCNH2 | |
| SCHEMBL8550231 | 0.88 | PPARG (0.56) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL8550222 | 0.88 | PPARG (0.56) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL9260216 | 0.87 | PPARG (0.53) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL8551814 | 0.87 | KDR (0.54) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL8551816 | 0.87 | KDR (0.54) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL9177105 | 0.87 | PPARG (0.53) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL6157414 | 0.87 | KDR (0.67) | PPARGPPARACYP2C9KCNH2KDR | |
| SCHEMBL8799608 | 0.87 | PPARG (0.61) | PPARGPPARACYP2C9KCNH2PTPN1 | |
| SCHEMBL9181501 | 0.86 | PPARG (0.57) | PPARGPPARACYP2C9KCNH2KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0759919-B1 | AZOLIDINEDIONES AS ANTIHYPERGLYCEMIC AGENTS | AMERICAN HOME PROD (US) | 1998-11-11 | — | — | EP | disclosed |
| CN-1152312-A | Novel pyrrolidinediones as antihyperglycemic agents | AMERICAN HOME PROD (US) | 1997-06-18 | — | — | CN | disclosed |
| EP-0759919-A1 | NEW AZOLIDINEDIONES AS ANTIHYPERGLYCEMIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-03-05 | — | — | EP | disclosed |
| US-5532256-A | ORALLY ADMINISTERED ANTIDIABETIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-07-02 | — | — | US | disclosed |
| WO-1995031454-A1 | NEW AZOLIDINEDIONES AS ANTIHYPERGLYCEMIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-11-23 | — | — | WO | disclosed |
| US-5468762-A | Antidiabetic agents for administering by mouth | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-11-21 | — | — | US | disclosed |
| US-5468760-A | Treating atherosclerosis, inflammation, and asthma | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-11-21 | — | — | US | disclosed |